Haboubi N Y, Edilbe M W, Hill J
Department of Surgical Pathology, Trafford Healthcare NHS Trust, Davyhulme, Manchester, UK.
Colorectal Dis. 2007 Mar;9(3):238-44. doi: 10.1111/j.1463-1318.2006.01091.x.
The currently accepted first line treatment for epidermoid anal cancer is chemoradiotherapy (CRT). Tumour size and adjacent organ involvement are the key in the pretreatment assessment for T1-T4 tumours respectively. Residual or recurrent disease following initial CRT, is best treated by salvage anorectal excision. Pathological staging systems of resections were historically validated when surgery was the primary treatment and are therefore in need of revision. We propose a new pathological staging system for salvage anorectal excision specimens to allow improved prognostic guidelines postoperatively.
目前公认的表皮样肛管癌一线治疗方法是放化疗(CRT)。肿瘤大小和相邻器官受累情况分别是T1 - T4肿瘤术前评估的关键。初始放化疗后残留或复发的疾病,最佳治疗方法是挽救性肛肠切除术。由于手术曾是主要治疗手段,切除标本的病理分期系统在历史上得到了验证,因此需要修订。我们提出一种用于挽救性肛肠切除标本的新病理分期系统,以便术后能有更好的预后指导方针。